Related Experiment Video

Updated: Jun 13, 2026

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer

Daniel Reimer1, Michael Hubalek, Svenja Riedle

  • 1Departments of Obstetrics and Gynecology and Radiotherapy, Innsbruck Medical University, Innsbruck, Austria.

Cancer Research
|May 13, 2010
PubMed

Insights

Scientists discovered a new molecular pathway linking epidermal growth factor receptor (EGFR) to E2F3a in ovarian cancer, essential for cell proliferation. This finding offers potential new therapeutic strategies for ovarian cancer treatment.

Area of Science:

  • Molecular biology
  • Oncology
  • Cell signaling

Background:

  • Epidermal growth factor receptor (EGFR) signaling is crucial in cell proliferation.
  • The role of transcription factors, particularly E2F family members, in EGFR-mediated signaling in ovarian cancer requires further elucidation.

Purpose of the Study:

  • To identify and characterize a novel molecular pathway connecting E2F3a and EGFR activation in ovarian cancer.
  • To investigate the role of E2F3a in EGFR-driven proliferation in ovarian cancer cells.

Main Methods:

  • Investigated E2F family member expression following EGFR activation in ovarian cancer cells and healthy cells.
  • Performed E2F3a knockdown experiments and assessed proliferation.
  • Analyzed the dependence of the EGFR-E2F3a axis on signal transducer and activator of transcription (STAT) 1/3 and interferon-regulatory factors (IRFs).
  • Conducted a pilot study on primary ovarian cancer specimens to correlate EGFR and E2F3a expression.

Main Results:

  • EGFR activation selectively upregulated E2F3a in ovarian cancer cells, unlike in healthy cells where E2F1 and E2F2 were upregulated.
  • EGF-induced proliferation in ovarian cancer cells correlated with E2F3a levels, and E2F3a knockdown inhibited proliferation even with EGF exposure.
  • The EGFR-E2F3a axis was dependent on STAT1/3 and IRF-1/IRF-2 ratio.
  • A significant correlation between activated EGFR and E2F3a expression was observed in primary ovarian cancer specimens.

Conclusions:

  • A novel molecular pathway linking E2F3a to EGFR activation, crucial for ovarian cancer cell proliferation, has been identified.
  • This EGFR-E2F3a axis provides new insights into EGFR signaling in ovarian cancer.
  • The identified pathway represents a potential therapeutic target for ovarian cancer treatment.

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...